Prime Vector Technologies

Curated by Signal

Developer of therapeutic vaccines against infectious diseases and cancer

Life Sciences Technologyprime-vector-technologies.com

Overview

Developer of therapeutic vaccines against infectious diseases and cancer. The company is developing prophylactic vaccines against cOVID-19, Respiratory Syncytial Virus, and therapeutic vaccines against cancer. Also, developing veterinary vaccines for various diseases.

Key facts

Founded: 2019
Headquarters: Tubingen, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Tomed
Products for Sleep and Women's Health
Life Sciences TechnologyCologne, Germany
F Bosch
Blood pressure monitors
Life Sciences TechnologyBisingen, Germany
Biobase
Provider of commercial biological databases for gene expression, pathway, and NGS analysis
Life Sciences TechnologyWolfenbuttel, Germany

About Prime Vector Technologies

What does Prime Vector Technologies do?

Developer of therapeutic vaccines against infectious diseases and cancer.

Where is Prime Vector Technologies headquartered?

Prime Vector Technologies is headquartered in Tubingen, Germany.

When was Prime Vector Technologies founded?

Prime Vector Technologies was founded in 2019.

Which sector is Prime Vector Technologies in?

Prime Vector Technologies operates in Life Sciences Technology.

Who are Prime Vector Technologies's competitors?

Companies similar to Prime Vector Technologies include Tomed, F Bosch, and Biobase.